3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
19
Breast Neoplasms
17
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myeloid, Acute
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Uveal Melanoma
2
Recurrence
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Glioblastoma
2
Genetic Predisposition to Disease
2
Fibrosis
2
Interventions
Temozolomide
7
Vincristine
5
Cyclophosphamide
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.